04:22 PM EDT, 03/21/2024 (MT Newswires) -- Medtronic ( MDT ) said Thursday it will now a federal court in California to resume its patent infringement lawsuit against Axonics after the US Patent and Trademark Office's Patent Trial and Appeal Board affirmed the validity of claims in two of its patents in the lawsuit over sacral neuromodulation technologies.
The board has now upheld the validity of five Medtronic ( MDT ) patents involved in the case, the company said.
Axonics did not immediately respond to a request for comment by MT Newswires.
Price: 83.41, Change: -0.01, Percent Change: -0.01